Cargando…
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19
COVID-19 patients exhibit differential disease severity after SARS-CoV-2 infection. It is currently unknown as to the correlation between the magnitude of neutralizing antibody (NAb) responses and the disease severity in COVID-19 patients. In a cohort of 59 recovered patients with disease severity i...
Autores principales: | Chen, Xiangyu, Pan, Zhiwei, Yue, Shuai, Yu, Fei, Zhang, Junsong, Yang, Yang, Li, Ren, Liu, Bingfeng, Yang, Xiaofan, Gao, Leiqiong, Li, Zhirong, Lin, Yao, Huang, Qizhao, Xu, Lifan, Tang, Jianfang, Hu, Li, Zhao, Jing, Liu, Pinghuang, Zhang, Guozhong, Chen, Yaokai, Deng, Kai, Ye, Lilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464057/ https://www.ncbi.nlm.nih.gov/pubmed/32879307 http://dx.doi.org/10.1038/s41392-020-00301-9 |
Ejemplares similares
-
The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity
por: Gao, Leiqiong, et al.
Publicado: (2021) -
Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical Trial
por: Lin, Yao, et al.
Publicado: (2022) -
Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody
por: Yue, Shuai, et al.
Publicado: (2021) -
Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
por: Chen, Xiangyu, et al.
Publicado: (2020) -
PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness
por: Chen, Xiangyu, et al.
Publicado: (2023)